I think we need to basically let the data come out and then we should interpret it in the

most rigorous way possible.

But we all hope for the best for the benefit of the world.

Dr. Dan Baruch is the director of the Center for Virology and Vaccine Research at Beth Israel

Deakinis Medical Center in Boston.

He's also helping develop Johnson and Johnson's COVID-19 vaccine candidate.

This from its phase three clinical trials are expected soon, possibly even this week.

And if all goes well, the country could potentially have a third vaccine authorized for use in

a month or two.

This is terrific news.

Johnson and Johnson's vaccine is just a single dose and it doesn't have to be stored

at a freezing temperature.

It could be a game changer for its distribution, eliminating some of the supply chain issues

that Pfizer, Biontech and Moderna's vaccines have faced.

Floridians caught in the botched COVID-19 vaccine rollout have been writing angry emails

to local officials.

And now that he's in charge, Biden's not holding back, calling the vaccine rollout program

a dismal failure.

So where are we now?

Well, nearly 20 million doses of the Pfizer and Moderna vaccines have been administered

in the United States.

That's far slower than was promised.

...